Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature

Marc KellinyDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA

Paul E CroarkinDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA

Katherine M MooreDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA

William V BoboDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USACorrespondence[email protected]

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (5)

Diego Santos García, Maria Gema Alonso Losada, Icíar Cimas Hernando, Iria Cabo López, Rosa Yáñez Baña, Ruben Alonso Redondo, Jose Manuel Paz González, Carlos Cores Bartolomé, Maria José Feal Painceiras, Maria Cristina Íñiguez Alvarado, Carmen Labandeira & Iago García Díaz. (2022) Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study. Brain Sciences 12:11, pages 1466.
Crossref

Luciani F, Papa E, Leggeri ACalabrese C, Condo ' R & Calabrese L. (2022) BURNING MOUTH DISEASE, MODERN TREATMENT AND CLINICAL MANAGEMENT: A NARRATIVE REVIEW. INDIAN JOURNAL OF APPLIED RESEARCH, pages 44-46.
Crossref

Grzegorz Ślifirski, Marek Król & Jadwiga Turło. (2021) 5-HT Receptors and the Development of New Antidepressants. International Journal of Molecular Sciences 22:16, pages 9015.
Crossref

Giovanni Ostuzzi, Chiara Gastaldon, Angelo Barbato, Barbara D’Avanzo, Mauro Tettamanti, Igor Monti, Andrea Aguglia, Eugenio Aguglia, Maria Chiara Alessi, Mario Amore, Francesco Bartoli, Massimo Biondi, Paola Bortolaso, Camilla Callegari, Giuseppe Carrà, Rosangela Caruso, Simone Cavallotti, Cristina Crocamo, Armando D’Agostino, Pasquale De Fazio, Chiara Di Natale, Laura Giusti, Luigi Grassi, Giovanni Martinotti, Michela Nosé, Davide Papola, Marianna Purgato, Alessandro Rodolico, Rita Roncone, Lorenzo Tarsitani, Giulia Turrini, Elisa Zanini, Francesco Amaddeo, Mirella Ruggeri & Corrado Barbui. (2020) Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial. Trials 21:1.
Crossref

Adam Bucki, Monika Marcinkowska, Joanna Śniecikowska, Krzysztof Więckowski, Maciej Pawłowski, Monika Głuch-Lutwin, Anna Gryboś, Agata Siwek, Karolina Pytka, Magdalena Jastrzębska-Więsek, Anna Partyka, Anna Wesołowska, Paweł Mierzejewski & Marcin Kołaczkowski. (2017) Novel 3-(1,2,3,6-Tetrahydropyridin-4-yl)-1 H -indole-Based Multifunctional Ligands with Antipsychotic-Like, Mood-Modulating, and Procognitive Activity . Journal of Medicinal Chemistry 60:17, pages 7483-7501.
Crossref

Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature

Articles from other publishers (5)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Profile of vortioxetine in the treatment of major depressive disorder: an overview of the primary and secondary literature

Citations (5)

Articles from other publishers (5)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date